Silvant Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.8K Buy
+385
New +$32.6K ﹤0.01% 322
2020
Q3
Sell
-6,644
Closed -$390K 334
2020
Q2
$390K Hold
6,644
0.07% 122
2020
Q1
$336K Hold
6,644
0.07% 121
2019
Q4
$492K Hold
6,644
0.09% 113
2019
Q3
$380K Hold
6,644
0.08% 123
2019
Q2
$435K Hold
6,644
0.08% 124
2019
Q1
$492K Hold
6,644
0.09% 115
2018
Q4
$396K Buy
6,644
+505
+8% +$40.7K 0.08% 123
2018
Q3
$580K Hold
6,139
0.07% 115
2018
Q2
$461K Buy
6,139
+550
+10% +$39.5K 0.06% 124
2018
Q1
$338K Buy
+5,589
New +$303K 0.04% 152

Other funds holding HQY

Silvant Capital Management's HQY Position: Q2 2026 in Review

Silvant Capital Management opened a new position in HealthEquity (HQY) in Q2 2026: 385 shares worth $34.8K. The stake represents ﹤0.01% of the portfolio and ranks #322 among its holdings. This is a return to the name: Silvant Capital Management previously reported a position in HQY as recently as Q2 2020.

Silvant Capital Management first reported a position in HQY in Q1 2018 and has held it in 11 quarters since. The position peaked at $580K in Q3 2018. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Silvant Capital Management held 385 shares of HealthEquity worth $34.8K as of Q2 2026.
  • HealthEquity was a new Silvant Capital Management position in Q2 2026.
  • HealthEquity made up ﹤0.01% of Silvant Capital Management's portfolio in Q2 2026, its #322 holding.
  • Silvant Capital Management first reported a position in HealthEquity in Q1 2018 and has held it in 11 quarters since.
  • Silvant Capital Management's HealthEquity position peaked at $580K in Q3 2018.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Silvant Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.